Christoph Brackmann

Insider Reports History

Location
Baar
Signature
Steven Robbins, as attorney in fact for Brackmann, Christoph
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christoph Brackmann:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Chief Financial Officer Ordinary Shares 134,117 $1,640,250 $12.23 04 Nov 2025 Direct
NovoCure Ltd Chief Financial Officer Stock Options (Right to buy) 81,499 $1,482,467 $18.19 04 Mar 2025 Direct
NovoCure Ltd Chief Financial Officer Restricted Share Units 60,277 01 Jan 2025 Direct

Insider Reports Filed by Christoph Brackmann

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVCR NovoCure Ltd 04 Nov 2025 1 -$86,014 4 Chief Financial Officer 04 Nov 2025, 16:10
NVCR NovoCure Ltd 29 Jul 2025 3 +$231,800 4 Chief Financial Officer 30 Jul 2025, 16:33
NVCR NovoCure Ltd 04 Mar 2025 2 +$2,482,462 4 Chief Financial Officer 06 Mar 2025, 16:48
NVCR NovoCure Ltd 01 Jan 2025 0 $0 3 CFO 06 Jan 2025, 16:10